IGC Pharma
26 hedge funds and large institutions have $1.31M invested in IGC Pharma in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $1.73M → $1.31M (-$422K)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
26
Holding in Top 10
–
Calls
$197K
Puts
$45K
Top Buyers
| 1 | +$55K | |
| 2 | +$43.8K | |
| 3 | +$19.9K | |
| 4 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
+$7K |
| 5 |
DP
Dearborn Partners
Chicago,
Illinois
|
+$5K |
Top Sellers
| 1 | -$60.5K | |
| 2 | -$54K | |
| 3 | -$37.3K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$30.2K |
| 5 |
VF
Virtu Financial
New York
|
-$24K |